ELDN — Eledon Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $186.90m
- $137.16m
Eledon Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Eledon Pharmaceuticals Posts Q3 Loss Per Share Of $0.66
Eledon Pharmaceuticals Inc expected to post a loss of 65 cents a share - Earnings Preview
Brief: CareDx And Eledon Pharmaceuticals Announce Collaborative Research Agreement
Eledon Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Eledon Pharmaceuticals Reports Second Quarter 2021 Operating And Financial Results
Eledon Pharmaceuticals Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Eledon Pharmaceuticals Receives Approval To Commence Human Trials For AT-1501
Brief: Eledon Pharmaceuticals Reports Q1 Loss Per Share $0.57
Eledon Pharmaceuticals Inc expected to post a loss of 32 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-BP Midstream Partners LP, Lyft, Proofpoint
Brief: Eledon Pharmaceuticals Inc - Announces Update On Development Strategy For At-1501 In Renal Transplantation
Brief: Eledon Pharmaceuticals Files For Mixed Shelf Of Up To $250 Mln
Brief: Eledon Pharmaceuticals Reports Fourth Quarter And Full-Year 2020 Operating And Financial Results
Brief: Eledon Pharma Appoints Paul Little As CFO
Brief: Novus Therapeutics Announces Name Change To Eledon Pharmaceuticals
Brief: Novus Therapeutics Files Prospectus Related To Proposed Resale, Other Disposition Of 12.4 Mln Shares By Selling Stockholders
Brief: Novus Therapeutics Appoints June Lee To Board Of Directors
Brief: Novus Therapeutics Reports Q3 2020 Financial Results